Corporate Social Responsibility som Pharma udviklingsvirksomhed
How does this Q&A work:
This company invites all interested, both current investors and potential investors to participate in this event, ask questions directly on this page before the event starts and upvote those questions you would like addressed.
The company will address as many questions as possible, and focus on those questions most wanted by investors.
Speakers at this event:
4 Questions
Feb. 28, 2024
When is management going to realize and admit that the holding structure is keeping new investors away from investing?
When will you tear down the holding structure and quit the PEG name and simply call Reponex REPONEX and have REPONEX listed directly and conventionally- as all shareholders expected?
Feb. 27, 2024
Analyst Group forventer at i leverer den første omsætning fra royalties i 2025. Det er allerede næste år. Hvornår kan man forvente at i indgår partner-aftaler med dertilhørende Royalties hvis de første allerede skal falde i 2025?
Feb. 27, 2024
Har i som virksomhed andre samarbejdspartnere ud over de danske grænser?
Feb. 27, 2024
Er der nogen økonomiske eller andre forretningsmæssige forhold i et samarbejde mellem jer og Colitis-Crohn Foreningen?